Almac Diagnostics expands its Bioinformatics department

Almac Diagnostics – a personalized medicine company announced the extension of its Bioinformatics department.

Almac has shown significant growth in the last year, with employee numbers growing by 15% in the UK and 10% in the US. For the Diagnostics division, this trend continues through the expansion of the Bioinformatics Department and the subsequent opening of a dedicated bioinformatics facility in Manchester (UK).

Professor Paul Harkin, President and Managing Director of Almac Diagnostics said: "With our commitment to the delivery of personalized medicine, we have extended our bioinformatics group to increase our expertise in companion diagnostic development, pharmacodynamic (PD) biomarkers, disease classification and prognostic markers. Our extended expert bioinformatics capability assists our dedication to the advancement of patient care through translational genomic solutions"

Almac's Bioinformatics group specialise in gene selection, disease characterisation and classification. Bioinformatics is well recognised as a major bottleneck in genomics and the expansion of the bioinformatics group greatly expands Almac's capacity and hence reduces this problem.